@article{penel_n_activity_2013,
title = {Activity endpoints reported in soft tissue sarcoma phase II trials: Quality of reported endpoints and correlation with overall survival},
volume = {88},
issn = {1040-8428},
url = {http://www.ncbi.nlm.nih.gov/pubmed/23706377},
DOI = {10.1016/j.critrevonc.2013.05.004},
Language = {English},
Journal = {Crit. Rev. Oncol./Hematol.},
author = {{Penel N} and {Cousin S} and {Duhamel A} and {Kramar A}},
year = {2013},
keywords = {Antineoplastic Agents/therapeutic use*, Clinical Trials, Phase II as Topic, Humans, Sarcoma/drug therapy*, Sarcoma/mortality*, Treatment Outcome},
pages = {309-317}
}

{"_id":"MdfqBPFGJ2kkumzLF","bibbaseid":"peneln-cousins-duhamela-kramara-activityendpointsreportedinsofttissuesarcomaphaseiitrialsqualityofreportedendpointsandcorrelationwithoverallsurvival-2013","authorIDs":[],"author_short":["Penel N","Cousin S","Duhamel A","Kramar A"],"bibdata":{"bibtype":"article","type":"article","title":"Activity endpoints reported in soft tissue sarcoma phase II trials: Quality of reported endpoints and correlation with overall survival","volume":"88","issn":"1040-8428","url":"http://www.ncbi.nlm.nih.gov/pubmed/23706377","doi":"10.1016/j.critrevonc.2013.05.004","language":"English","journal":"Crit. Rev. Oncol./Hematol.","author":[{"firstnames":[],"propositions":[],"lastnames":["Penel N"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Cousin S"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Duhamel A"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["Kramar A"],"suffixes":[]}],"year":"2013","keywords":"Antineoplastic Agents/therapeutic use*, Clinical Trials, Phase II as Topic, Humans, Sarcoma/drug therapy*, Sarcoma/mortality*, Treatment Outcome","pages":"309-317","bibtex":"@article{penel_n_activity_2013,\r\ntitle = {Activity endpoints reported in soft tissue sarcoma phase II trials: Quality of reported endpoints and correlation with overall survival},\r\nvolume = {88},\r\nissn = {1040-8428},\r\nurl = {http://www.ncbi.nlm.nih.gov/pubmed/23706377},\r\nDOI = {10.1016/j.critrevonc.2013.05.004},\r\nLanguage = {English},\r\nJournal = {Crit. Rev. Oncol./Hematol.},\r\nauthor = {{Penel N} and {Cousin S} and {Duhamel A} and {Kramar A}},\r\nyear = {2013},\r\nkeywords = {Antineoplastic Agents/therapeutic use*, Clinical Trials, Phase II as Topic, Humans, Sarcoma/drug therapy*, Sarcoma/mortality*, Treatment Outcome},\r\npages = {309-317}\r\n}\r\n\r\n","author_short":["Penel N","Cousin S","Duhamel A","Kramar A"],"key":"penel_n_activity_2013","id":"penel_n_activity_2013","bibbaseid":"peneln-cousins-duhamela-kramara-activityendpointsreportedinsofttissuesarcomaphaseiitrialsqualityofreportedendpointsandcorrelationwithoverallsurvival-2013","role":"author","urls":{"Paper":"http://www.ncbi.nlm.nih.gov/pubmed/23706377"},"keyword":["Antineoplastic Agents/therapeutic use*","Clinical Trials","Phase II as Topic","Humans","Sarcoma/drug therapy*","Sarcoma/mortality*","Treatment Outcome"],"downloads":0},"bibtype":"article","biburl":"https://pro.univ-lille.fr/fileadmin/user_upload/pages_pros/patrick_devos/duhamel.bib","creationDate":"2019-06-21T09:30:55.068Z","downloads":0,"keywords":["antineoplastic agents/therapeutic use*","clinical trials","phase ii as topic","humans","sarcoma/drug therapy*","sarcoma/mortality*","treatment outcome"],"search_terms":["activity","endpoints","reported","soft","tissue","sarcoma","phase","trials","quality","reported","endpoints","correlation","overall","survival","penel n","cousin s","duhamel a","kramar a"],"title":"Activity endpoints reported in soft tissue sarcoma phase II trials: Quality of reported endpoints and correlation with overall survival","year":2013,"dataSources":["Tt6zYqvN5kE3wbwiR"]}